24 May 2013
Keywords: merck, serono, launches, kuvan, europe, division, germany
Article | 23 April 2009
Merck Serono, a division of Germany's Merck KGaA, has launched Kuvan (sapropterin dihydrochloride) in Europe. The drug is indicated for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 April 2009
22 April 2009
23 May 2013
© 2013 thepharmaletter.com